NF2 Deficient Mesothelioma
specificA preinvasive mesothelial neoplasm that arises on the surfaces that contain mesothelial lining (pleura, peritoneum, pericardium, and tunica vaginalis) and is characterized by the proliferation of mesothelial cells in a single layer without invasion into underlying tissues. It requires demonstration of nuclear BAP1 loss or cytoplasmic MTAP loss by immunohistochemistry, or CDKN2A homozygous deletion by FISH. It is a precursor lesion to malignant mesothelioma, it most often affects the pleura, and
6
Centers
0
Active Trials
—
Cancer Funding
Top Centers for NF2 Deficient Mesothelioma(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 58.3 |
| 2 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 58.3 |
| 3 | NCI Comprehensive | 58.3 |
| 4 | University of Illinois Cancer CenterChicago, IL | 58.3 |
| 5 | Boston University Cancer CenterBoston, MA | 58.3 |
| 6 | Cancer Center at IllinoisUrbana, IL | 58.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →